Homepage News
Mabwell's Adalimumab Injection Approved for Marketing in Indonesia
2025-12-31
Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
2025-12-30
Ipsen Outlays $1BN for China-Based Simcere’s Preclinical ADC
2025-12-28
China’s Jacobio Inks Immuno-Oncology Deal Worth $1.9 B With AstraZeneca
2025-12-26
Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan Ipark in Japan
2025-12-26
US FDA Approves Omeros’ Drug to Treat Dangerous Transplant Complication
2025-12-25
Sanofi Pushes Ahead on Adult Vaccines With $2.2 Billion Dynavax Deal
2025-12-25
  • Asia
  • South America
  • North America
  • Oceania
  • Africa
  • Europe
    • China Mongolia North Korea South Korea Japan Philippines Vietnam Laos Cambodia Myanmar Thailand Malaysia Brunei Darussalam Singapore Indonesia East Timor Nepal Bhutan Bangladesh India Pakistan Sri Lanka Maldives Kazakhstan Kyrgyzstan Tajikistan Uzbekistan Turkmenistan Afghanistan Iraq Iran Syria Jordan Lebanon Israel Palestine Saudi Arabia Bahrain Qatar Kuwait United Arab Emirates Oman Yemen Georgia Armenia Azerbaijan Turkey
    Healthcare Engineering
    More
    U.S. Food and Drug Administration (FDA) Approves Omeros' New Drug Yartemlea for the Treatment of Transplant Complication TA-TMA
    Wedoany.com Report-Dec.31, The U.S. Food and Drug Administration (FDA) has officially approved Yarte...
    2025-12-31
    Mabwell's Adalimumab Injection Approved for Marketing in Indonesia
    Wedoany.com Report-Dec.31, Mabwell (688062.SH), an innovative biopharmaceutical company with a full ...
    2025-12-31
    Osaikang Pharma and Adlai Nortye Enter into License Agreement for Type 1 Innovative Drug AN9025 Project
    Wedoany.com Report-Dec.30, Osaikang announced that its subsidiary Jiangsu Osaikang Pharmaceutical Co...
    2025-12-30
    Ipsen Outlays $1BN for China-Based Simcere’s Preclinical ADC
    Wedoany.com Report-Dec.28, Ipsen has entered into an exclusive licensing agreement with Simcere Zaim...
    2025-12-28
    China’s Jacobio Inks Immuno-Oncology Deal Worth $1.9 B With AstraZeneca
    Wedoany.com Report-Dec.26, China-based Jacobio Pharma (1167.HK) has entered into a global exclusive ...
    2025-12-26
    Asahi Kasei Pharma to Relocate Global R&D Hub to Shonan Ipark in Japan
    Wedoany.com Report-Dec.26, Asahi Kasei Pharma Corporation has announced plans to relocate its R&...
    2025-12-26
    US FDA Approves Omeros’ Drug to Treat Dangerous Transplant Complication
    Wedoany.com Report-Dec.25, Omeros Corporation announced on Wednesday that the U.S. Food and Drug Adm...
    2025-12-25
    Sanofi Pushes Ahead on Adult Vaccines With $2.2 Billion Dynavax Deal
    Wedoany.com Report-Dec.25, Sanofi announced on Wednesday, December 24, 2025, that it has entered int...
    2025-12-25
    Agios Pharma Shares Jump as US FDA Expands Approval for Blood Disorder Drug
    Wedoany.com Report-Dec.25, Agios Pharmaceuticals announced late on Tuesday that the U.S. Food and Dr...
    2025-12-25
    Sinocare Receives Medical Device Registration Certificates for Multiple Products
    Sinocare announced on December 23 that its Blood Glucose, Uric Acid, and Blood Ketone Analyzer, Bloo...
    2025-12-24
    US Health Agency Unveils Weight-Loss Drug Coverage Model
    Wedoany.com Report-Dec.24, The U.S. Centers for Medicare and Medicaid Services announced a voluntary...
    2025-12-24
    Novo Nordisk Wins US Approval for Weight-Loss Pill
    Wedoany.com Report-Dec.24, The U.S. Food and Drug Administration approved Novo Nordisk's oral weigh...
    2025-12-24